In humans with non-insulin dependent diabetes mellitus (NIDDM), vanadium can reduce fasting blood glucose and glycosylated hemoglobin levels, reduces hepatic glucose release, and increases peripheral glucose disposal and uptake into skeletal muscle mediated by insulin. Vanadium does not influence blood glucose levels in normal patients. While the exact mechanism of action of vanadium is unknown, it apparently inhibits protein tyrosine phosphatase (PTP). PTP is important in signal transduction and allows vanadium to act via both insulin-dependent and insulin-independent pathways.
Vancomycin should only be used to treat infections that are documented resistant to other antibiotics and susceptible to vancomycin, usually methicillin-resistant _Staphylococcus_ spp. (MRSA) or multidrug-resistant _Enterococcus_ spp. It potentially is useful for oral treatment of pseudomembranous colitis caused by _Clostridia_ _difficile_ .
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
API 無法同時鎖定精確釩化合物、氧化態、鹽／水合態、元素當量、完整產品成分與效價、物種、自然發生疾病、現行指南角色、法規、毒性及監測。16 張數值證據卡全不可執行；舊貓用元素／鹽類／複方劑量、alloxan 犬模型及異藥 Deferoxamine 劑量均由 overlay 清空。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
renal